Key facts
- This page summarizes John E. Kao's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Mar 2025, 19:27.
John E. Kao - 04 Mar 2025 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- ALHC
- Reported as of
- 04 Mar 2025
- Net transaction value
- -$8,614,693
- SEC form
- 4
- Accepted by SEC
- 06 Mar 2025, 19:27:43 UTC
- Prior SEC filing
- 12 Feb 2025
- Next SEC filing
- 13 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Kao filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 06 Mar 2025.
Change
- Previous filing in this sequence was filed on 12 Feb 2025.
- Current net transaction value: -$8,614,693.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALHC
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,543,124
- Change %
- +93%
- Price
- $0.000000
- Shares after
- 5,288,377
- Date
- 04 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
ALHC
transaction
Common Stock
Sale
- Transaction value
- $8,614,693
- Shares
- -554,713
- Change %
- -10%
- Price
- $15.53
- Shares after
- 4,733,664
- Date
- 06 Mar 2025
- Ownership
- Direct
- Footnotes
- F2, F3
ALHC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,183,100
- Date
- 04 Mar 2025
- Ownership
- See Footnote
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents shares of common stock that were acquired upon the certification by the Compensation Committee of the Alignment Healthcare, Inc. Board of Directors of the achievement of the performance objectives under performance share units ("PSUs") granted on September 14, 2023. The PSUs were scheduled to vest only if and to the extent that certain performance objectives (health plan revenue growth percentage, at-risk returning member medical benefit ratio and adjusted EBITDA, less capital expenditures) met or exceeded specified targets. In the aggregate, the performance objectives were achieved above target. Fifty percent (50%) of the granted PSUs were fully vested on the reported date of acquisition and fifty percent (50%) will become vested on December 31, 2025, subject to the reporting person's continued service to the Company on such vesting date.
Footnote F2
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs. This transaction does not represent a discretionary trade by the reporting person.
Footnote F3
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.12 to $16.065. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Footnote F4
Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.